The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: vincristine     Quarter: 2016Q3

Total Records: 1,179     Number of Pages: 59

DRUGNAME PT EventCount
VINCRISTINE Seizure 4
Vincristine Therapeutic response decreased 4
VINCRISTINE Transfusion 4
Vincristine Treatment failure 4
VINCRISTINE Tumour haemorrhage 4
VINCRISTINE Urosepsis 4
vincristine Venoocclusive liver disease 4
VINCRISTINE HOSPIRA Campylobacter gastroenteritis 4
VINCRISTINE HOSPIRA Septic shock 4
VINCRISTINE SULFATE. Acute lymphocytic leukaemia recurrent 4
VINCRISTINE SULFATE. Aspartate aminotransferase increased 4
VINCRISTINE SULFATE. Asthenia 4
VINCRISTINE SULFATE. Azotaemia 4
VINCRISTINE SULFATE. Candida infection 4
VINCRISTINE SULFATE. Chills 4
VINCRISTINE SULFATE. Coagulopathy 4
VINCRISTINE SULFATE. Fluid overload 4
VINCRISTINE SULFATE. Gamma-glutamyltransferase increased 4
VINCRISTINE SULFATE. Gastrointestinal necrosis 4
VINCRISTINE SULFATE. Graft versus host disease 4

Total Records: 1,179     Number of Pages: 59